TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biosupply AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,393
|
1,301
|
1,157 |
| Financial expenses |
6
|
4
|
2 |
| Earnings before taxes |
112
|
-60
|
-31 |
| Total assets |
577
|
544
|
547 |
| Current assets |
352
|
302
|
323 |
| Current liabilities |
94
|
116
|
139 |
| Equity capital |
411
|
326
|
408 |
| - share capital |
267
|
285
|
301 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.2%
|
59.9%
|
74.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
8.0%
|
-4.6%
|
-2.7% |
| Return on assets (ROA) |
20.5%
|
-10.3%
|
-5.3% |
| Current ratio |
374.5%
|
260.3%
|
232.4% |
| Return on equity (ROE) |
27.3%
|
-18.4%
|
-7.6% |
| Change turnover |
175
|
204
|
110 |
| Change turnover % |
14%
|
19%
|
10% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.